-
What are the drug interactions between the birth control pill and semaglutide (Ozempic)? Perspective is important because the interaction is no different than many other medications used with the birth control pill.
Medical Mythbusting Commentary for June 25, 2025 Source:‘Ozempic babies’ and birth control: U.K. warning raises concerns over weight-loss drugs
-
Specialized JAK inhibitor anti-inflammatory drugs may leave body open to viral attacks, study suggests
Medical Mythbusting Commentary for June 9, 2025 Source:Common anti-inflammatory drugs may leave body open to viral attacks, study suggests Reference:JAK inhibitors remove innate immune barriers facilitating viral propagation
-
Two new cancer drugs approved for use in Sask., offering more treatment options
Medical Mythbusting Commentary for April 21, 2025 Source:Two new cancer drugs approved for use in Sask., offering more treatment options
-
A preprint, non-peer-reviewed study states that weight-loss drugs such as Wegovy are more likely to cause temporary hair loss compared to Contrave. The latter is not overly efficacious hence less weight loss therefore less hair loss.
Medical Mythbusting Commentary for March 18, 2025 Source:Weight-Loss Drugs Like Wegovy Are Linked to Hair Loss Reference:Risk of Hair Loss with Semaglutide for Weight Loss
-
The promotion of testosterone replacement as men age is a Pharma-industry-created problem. Most men do not need it. Blood tests can determine the true state of testosterone levels and if abnormally low, treated.
Medical Mythbusting Commentary for March 13, 2025 Source:Testosterone therapy’s popular in the online ‘manosphere’ — but doctor warns it’s not for everyone
-
Interesting research evaluating the effect sleeping pills have on the brain’s ability to restore itself during a specific sleep stage.
Medical Mythbusting Commentary for February 12, 2025 Source:Common sleep medication may prevent brain from clearing ‘waste’ Reference:Norepinephrine-mediated slow vasomotion drives glymphatic clearance during sleep
-
Research into new pain management medication options has produced a new pain pill approved in U.S. designed to cut risk of addiction
Medical Mythbusting Commentary for February 5, 2025 Source:New pain pill approved in U.S. designed to cut risk of addiction
-
Danish studies find higher risk of optic nerve damage with Ozempic however absolute risk increase is 1 in 10,000 and biological mechanism to explain this remains elusive.
Medical Mythbusting Commentary for January 17, 2025 Source:Danish studies find higher risk of optic nerve damage with Ozempic Reference:Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes